Brinzolamide nanocrystal formulations for ophthalmic delivery: Reduction of elevated intraocular pressure in vivo
Tuomela A., Liu P., Puranen J., Rönkkö S., Laaksonen T., Kalesnykas G., Oksala O., Ilkka J., Laru J., Järvinen K., Hirvonen J., Peltonen L.
View publication
-
Technology
Drug Delivery
-
Affiliations
Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland; Department of Ophthalmology, School of Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland; Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland; Santen Oy, Tampere, Finland; Oy Medfiles Ltd., Kuopio, Finland; Orion Pharma RandD, Formulation Research, Espoo, Finland